Anti-ACHA4/ CHRNA4/ BFNC monoclonal antibody

Anti-ACHA4/ CHRNA4/ BFNC antibody for FACS & in-vivo assay

Target products collectionGo to CHRNA4/CHRNA4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T70967-Ab-1/ GM-Tg-hg-T70967-Ab-2Anti-Human CHRNA4 monoclonal antibodyHuman
GM-Tg-rg-T70967-Ab-1/ GM-Tg-rg-T70967-Ab-2Anti-Rat CHRNA4 monoclonal antibodyRat
GM-Tg-mg-T70967-Ab-1/ GM-Tg-mg-T70967-Ab-2Anti-Mouse CHRNA4 monoclonal antibodyMouse
GM-Tg-cynog-T70967-Ab-1/ GM-Tg-cynog-T70967-Ab-2Anti-Cynomolgus/ Rhesus macaque CHRNA4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T70967-Ab-1/ GM-Tg-felg-T70967-Ab-2Anti-Feline CHRNA4 monoclonal antibodyFeline
GM-Tg-cang-T70967-Ab-1/ GM-Tg-cang-T70967-Ab-2Anti-Canine CHRNA4 monoclonal antibodyCanine
GM-Tg-bovg-T70967-Ab-1/ GM-Tg-bovg-T70967-Ab-2Anti-Bovine CHRNA4 monoclonal antibodyBovine
GM-Tg-equg-T70967-Ab-1/ GM-Tg-equg-T70967-Ab-2Anti-Equine CHRNA4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T70967-Ab-1/ GM-Tg-hg-T70967-Ab-2; GM-Tg-rg-T70967-Ab-1/ GM-Tg-rg-T70967-Ab-2;
GM-Tg-mg-T70967-Ab-1/ GM-Tg-mg-T70967-Ab-2; GM-Tg-cynog-T70967-Ab-1/ GM-Tg-cynog-T70967-Ab-2;
GM-Tg-felg-T70967-Ab-1/ GM-Tg-felg-T70967-Ab-2; GM-Tg-cang-T70967-Ab-1/ GM-Tg-cang-T70967-Ab-2;
GM-Tg-bovg-T70967-Ab-1/ GM-Tg-bovg-T70967-Ab-2; GM-Tg-equg-T70967-Ab-1/ GM-Tg-equg-T70967-Ab-2
Products NameAnti-CHRNA4 monoclonal antibody
Formatmab
Target NameCHRNA4
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CHRNA4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ACHA4/ CHRNA4/ BFNC VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP002918human CHRNA4 Lentivirus particle
    ORF Viral VectorpGMLP002918human CHRNA4 Lentivirus plasmid


    Target information

    Target IDGM-T70967
    Target NameCHRNA4
    Gene ID1137,11438,25590,114670571,485972,101101300,537251,100146784
    Gene Symbol and SynonymsAcra-4,Acra4,BFNC,CHRNA4,EBN,EBN1,ENFL1,NACHR,NACHRA4,NACRA4,NARAC
    Uniprot AccessionP43681,P09483
    Uniprot Entry NameACHA4_HUMAN,ACHA4_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000101204
    Target ClassificationIon Channel

    The target: CHRNA4, gene name: CHRNA4, also named as BFNC, EBN, EBN1, NACHR, NACHRA4, NACRA4. This gene encodes a nicotinic acetylcholine receptor, which belongs to a superfamily of ligand-gated ion channels that play a role in fast signal transmission at synapses. These pentameric receptors can bind acetylcholine, which causes an extensive change in conformation that leads to the opening of an ion-conducting channel across the plasma membrane. This protein is an integral membrane receptor subunit that can interact with either nAChR beta-2 or nAChR beta-4 to form a functional receptor. Mutations in this gene cause nocturnal frontal lobe epilepsy type 1. Polymorphisms in this gene that provide protection against nicotine addiction have been described. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.